Global Medical Microbiology Testing Technologies Market to Reach $3.7 Billion by 2030
The global market for Medical Microbiology Testing Technologies estimated at US$2.8 Billion in the year 2023, is expected to reach US$3.7 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2023-2030. Microbiology Testing Technologies for Respiratory Diseases, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Microbiology Testing Technologies for Neurological Diseases segment is estimated at 3.5% CAGR for the next 7-year period.
The U.S. Market is Estimated at $730 Million, While China is Forecast to Grow at 7.1% CAGR
The Medical Microbiology Testing Technologies market in the U.S. is estimated at US$730 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$864.7 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.3% and 3% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 2% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$556.6 Million by the year 2030.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook